LH Nov 2024 220.000 put
- PR Newswire
Labcorp Announces New Strategic Service Offerings within Precision Oncology Portfolio
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced new strategic service offerings within its precision oncology portfolio. The enhancements strengthen Labcorp's leadership as a premier, single-source partner for biopharmaceutical companies in advancing cancer research and patient care both in the United States and globally.
- PR Newswire
Labcorp to Present Multiple Abstracts across Precision Oncology at the 2024 ASCO Annual Meeting
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, will present several abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago (May 31 – June 4, 2024).
- PR Newswire
Labcorp to Speak at the 44th Annual William Blair Growth Stock Conference
Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that members of the executive management team will participate in a presentation at the 44th Annual William Blair Growth Stock Conference on Tuesday, June 4 at 2:00 p.m. (CT).
